CLINICAL RESEARCH: HEART RHYTHM DISORDER
Characteristics of Recurrent Ventricular Fibrillation Associated With Inferolateral Early RepolarizationRole of Drug Therapy
Michel Haïssaguerre, MD*,*,
Frederic Sacher, MD*,
Akihiko Nogami, MD#,
Nohiriro Komiya, MD**,
Anne Bernard, MD ,
Vincent Probst, MD, PhD ,
Sinikka Yli-Mayry, MD||||,
Pascal Defaye, MD ,
Yoshifusa Aizawa, MD ,
Robert Frank, MD||,
Roberto Mantovan, MD ,
Riccardo Cappato, MD ,
Christian Wolpert, MD¶¶,
Antoine Leenhardt, MD||,
Luc de Roy, MD  ,
Hein Heidbuchel, MD  ,
Isabel Deisenhofer, MD##,
Thomas Arentz, MD***,
Jean-Luc Pasquié, MD, PhD¶,
Rukshen Weerasooriya, MD*,
Meleze Hocini, MD*,
Pierre Jais, MD*,
Nicolas Derval, MD*,
Pierre Bordachar, MD* and
Jacques Clémenty, MD*
* Université Bordeaux, CHU Bordeaux, Bordeaux, France
Centre Hospitalier Universitaire de Tours, Tours, France
Centre Hospitalier Universitaire de Nantes, Nantes, France
Centre Hospitalier Universitaire de Grenoble, Grenoble, France
|| Centre Hospitalier Universitaire de Paris, Paris, France
¶ Centre Hospitalier Universitaire de Montpellier, Montpellier, France
# Yokohama Rosai Hospital, Yokohama, Japan
** Nagasaki University, Nagasaki, Japan
 Niigata University School, Niigata, Japan
 Treviso Hospital, Treviso, Italy
 Policlinico San Donato, Milano, Italy
|||| Tampere University Hospital, Tampere, Finland
¶¶ University Hospital Mannheim, Mannheim, Germany
## University Hospital Herzzentrum Munich, Munich, Germany
*** University Hospital Bad Krozingen, Bad Krozingen, Germany
  University Hospital Leuven, Leuven, Belgium
  Clinique MontGodinne, MontGodinne, Belgium
Manuscript received July 22, 2008;
revised manuscript received October 8, 2008,
accepted October 26, 2008.
* Reprint requests and correspondence: Dr. Michel Haïssaguerre, Hôpital Cardiologique du Haut-Lévêque, 33604 Bordeaux-Pessac, France (Email: michel.haissaguerre{at}chu-bordeaux.fr).
Objectives: Our purpose was to evaluate the efficacy of antiarrhythmic drugs (AADs) in recurrent ventricular fibrillation (VF) associated with inferolateral early repolarization pattern on the electrocardiogram.
Background: Although an implantable cardioverter-defibrillator is the treatment of choice, additional AADs may be necessary to prevent frequent episodes of VF and reduce implantable cardioverter-defibrillator shock burden or as a lifesaving therapy in electrical storms.
Methods: From a multicenter cohort of 122 patients (90 male subjects, age 37 ± 12 years) with idiopathic VF and early repolarization abnormality in the inferolateral leads, we selected all patients with more than 3 episodes of VF (multiple) including those with electrical storms ( 3 VF in 24 h). The choice of AAD was decided by individual physicians. Follow-up data were obtained for all patients using monitoring with implantable defibrillator. Successful oral AAD was defined as elimination of all recurrences of VF with a minimal follow-up period of 12 months.
Results: Multiple episodes of VF were observed in 33 (27%) patients. Electrical storms (34 ± 47 episodes) occurred in 16 and were unresponsive to beta-blockers (11 of 11), lidocaine/mexiletine (9 of 9), and verapamil (3 of 3), while amiodarone was partially effective (3 of 10). In contrast, isoproterenol infusion immediately suppressed electrical storms in 7 of 7 patients. Over a follow-up of 69 ± 58 months, oral AADs were poorly effective in preventing recurrent VF: beta-blockers (2 of 16), verapamil (0 of 4), mexiletine (0 of 4), amiodarone (1 of 7), and class 1C AADs (2 of 9). Quinidine was successful in 9 of 9 patients, decreasing recurrent VF from 33 ± 35 episodes to nil for 25 ± 18 months. In addition, quinidine restored a normal electrocardiogram.
Conclusions: Multiple recurrences of VF occurred in 27% of patients with early repolarization abnormality and may be life threatening. Isoproterenol in acute cases and quinidine in chronic cases are effective AADs.
Key Words: early repolarization sudden cardiac death ventricular fibrillation electrical storm antiarrhythmic drugs
|
Abbreviations and Acronyms
| | AAD = antiarrhythmic drug | | ICD = implantable cardioverter-defibrillator | | IQR = interquartile range | | VF = ventricular fibrillation |
|
Related Articles
-
Idiopathic Ventricular Fibrillation "Le Syndrome d'Haïssaguerre" and the Fear of J Waves
- Sami Viskin
J. Am. Coll. Cardiol. 2009 53: 620-622.
[Full Text]
[PDF]
-
Inside This Issue
J. Am. Coll. Cardiol. 2009 53: A32.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
S. Kamakura, T. Ohe, K. Nakazawa, Y. Aizawa, A. Shimizu, M. Horie, S. Ogawa, K. Okumura, K. Tsuchihashi, K. Sugi, et al.
Long-Term Prognosis of Probands With Brugada-Pattern ST-Elevation in Leads V1-V3
Circ Arrhythm Electrophysiol,
October 1, 2009;
2(5):
495 - 503.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. M. Marcus, E. Keung, and M. M. Scheinman
The year in review of clinical cardiac electrophysiology.
J. Am. Coll. Cardiol.,
August 25, 2009;
54(9):
777 - 787.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Viskin
Idiopathic Ventricular Fibrillation "Le Syndrome d'Haissaguerre" and the Fear of J Waves.
J. Am. Coll. Cardiol.,
February 17, 2009;
53(7):
620 - 622.
[Full Text]
[PDF]
|
 |
|
|